Proscia Announces Webinar
recent articles
PreciseDx study analyzes more than 2,000 patient samples, confirming the technology delivers more accurate, objective, diagnostic data than traditional testing. January 23, 2023 — PreciseDx, a leading innovator in AI-powered,...
Crescendo Health’s real-world data platform creates partnerships between researchers and patients to gain greater longitudinal insights into health outcomes from clinical research. Company also raises initial funding from top investors;...
Today, Nature Medicine published groundbreaking Owkin research demonstrating the first-ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data. At Owkin, we are on a journey to...
Epredia: Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program WINSTON-SALEM, N.C.--(BUSINESS WIRE)--PHC Group, a global healthcare company and leader in diagnostics and life sciences, will expand its presence in...
Proscia: Transition to modern digital pathology will improve patient care and enable new research breakthroughs AMSTERDAM and PHILADELPHIA – January 18, 2023 – Proscia®, a leading provider of digital and computational pathology...
Imogen Fitt of Signify Research attended the 9th Digital Pathology and AI Congress: Europe in December. In the article below she shares her thoughts on the conference with respect to recent industry discourse. News of Fujifilm’s recent...
